Compare CCSI & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCSI | VALN |
|---|---|---|
| Founded | 2021 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.6M | 536.9M |
| IPO Year | 2022 | 2021 |
| Metric | CCSI | VALN |
|---|---|---|
| Price | $29.70 | $6.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $37.50 | $15.50 |
| AVG Volume (30 Days) | ★ 148.2K | 33.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $349,696,000.00 | N/A |
| Revenue This Year | $3.33 | N/A |
| Revenue Next Year | $2.70 | $93.87 |
| P/E Ratio | $21.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.42 | $5.06 |
| 52 Week High | $37.30 | $12.25 |
| Indicator | CCSI | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 56.80 | 53.90 |
| Support Level | $25.35 | $5.81 |
| Resistance Level | $30.30 | $6.53 |
| Average True Range (ATR) | 2.21 | 0.24 |
| MACD | -0.07 | 0.12 |
| Stochastic Oscillator | 32.92 | 62.05 |
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.